Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05987774 · ClinicalTrials.gov registry record · NA
Improving Social Communication in Individuals With ASD Using AI
A NA study of Autism Spectrum Disorder, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 540
- Enrollment target
- 1
- Study location
NCT05987774: Recruiting NA study of Autism Spectrum Disorder, sponsored by Stanford University.
NCT05987774 is a NA study of Autism Spectrum Disorder that is actively recruiting participants, run by Stanford University. The registered enrollment target is 540 participants, above the 133-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (306% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05987774, a NA study of Autism Spectrum Disorder, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 540 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify whether researched and commonly used face-to-face interventions can be effectively implemented through artificial intelligence (AI) using an application on the phone or computer. The investigators plan to recruit verbal individuals diagnosed with autism spectrum disorder who demonstrate challenges with socialization. Modules focusing on various difficulties experienced by autistic individuals will provide practice and feedback using voice recognition and feedback. If effective, this intervention can be scaled up to provide cost-effective accessible assistance to individuals, particularly those who do not have access to care or prefer to secure services in the comfort of their own homes.
Primary Outcome
Measured in terms of what percentage of responses (0% - 100%) during the investigators' social conversation sample are answered appropriately for adolescents and adults or number of spoken words for young children. Each of the participants' responses will be evaluated by a MA or PhD-level expert. Social communication samples will be collected via Zoom, recorded and computer transcribed, after which recordings will be erased. An initial sample will be collected at baseline, after four weeks of in
Conditions Studied
Interventions
- DEVICE AI Modules for Improving Social Conversation
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 540 participants |
| Start Date | 2023-10-15 |
| Est. Completion | 2050-06-30 |
| Phase | NA |
What NCT05987774 shows while recruiting
NCT05987774 is an interventional study that assigns participants to a tested intervention. The registered 540 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (306% higher).
The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which AI Modules for Improving Social Conversation is the first listed.
NCT05987774 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05987774 about?
NCT05987774 is a clinical study titled "Improving Social Communication in Individuals With ASD Using AI". The purpose of this study is to identify whether researched and commonly used face-to-face interventions can be effectively implemented through artificial intelligence (AI) using an application on the phone or computer. The investigators plan to recruit verbal individuals diagnosed with autism spect...
What is the current status of trial NCT05987774?
This trial is currently recruiting. It is a NA study. The enrollment target is 540 participants. The study started on 2023-10-15. Estimated completion is 2050-06-30.
What conditions does trial NCT05987774 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder.
What interventions are being tested in trial NCT05987774?
The interventions under investigation include: AI Modules for Improving Social Conversation (DEVICE).
Who is sponsoring clinical trial NCT05987774?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05987774 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05987774's enrollment target sits among peer trials
540 10th of 224 higher than 215 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04557462 · 540 participants · Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- NCT04956640 · 540 participants · Phase 1
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
- NCT05429892 · 540 participants · NA
FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers
- NCT05549297 · 540 participants · Phase 3
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI